Stanford researchers have developed a new transcatheter, minimally invasive neochordal device for repair of mitral regurgitation, which does not require open heart surgery nor cardiopulmonary bypass.
Coronary artery bypass grafting (CABG) surgery is performed on nearly half a million patients with multivessel or diffuse coronary artery disease each year in the United States.